Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| GENAERA CORP | 300,000 | reported | 11 Aug 2008 | tx 6+725,417−417 |
| Vallon Pharmaceuticals, Inc. | 50,000 | reported | 15 Feb 2022 | tx 5+126,250 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Feb 2022 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 50,000 | 5.63 USD | deriv |
| 02 Jun 2021 | PURCHASE | Vallon Pharmaceuticals, Inc. | 3,657 | 4.00 USD | |
| 04 Jun 2021 | PURCHASE | Vallon Pharmaceuticals, Inc. | 1,508 | 4.08 USD | |
| 03 Jun 2021 | PURCHASE | Vallon Pharmaceuticals, Inc. | 1,085 | 4.05 USD | |
| 14 May 2021 | GRANT_AWARD | Vallon Pharmaceuticals, Inc. | 70,000 | 0.00 USD | deriv |
| 11 Aug 2008 | GRANT_AWARD | GENAERA CORP | 300,000 | 0.00 USD | deriv |
| 11 Dec 2007 | EXERCISE | GENAERA CORP | 417 | 0.00 USD | |
| 11 Dec 2007 | EXERCISE | GENAERA CORP | 417 | 0.00 USD | deriv |
| 26 Sept 2007 | GRANT_AWARD | GENAERA CORP | 275,000 | 0.00 USD | deriv |
| 18 May 2007 | GRANT_AWARD | GENAERA CORP | 100,000 | 0.00 USD | deriv |
| 01 May 2007 | GRANT_AWARD | GENAERA CORP | 50,000 | 0.00 USD | deriv |